Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q2 2021 call → NOWe need answer YES/NO. Need analyze transcript. Question asks: does management describe company as currently in middle of copying a part of its own business that is already working into additional places where same demand is already visible? Need identify specific proven instance, copies being stood up now, demand already identified at destination, replication large relative to company, results reflect original instance. Transcript: Catalyst Pharmaceuticals, Firdapse for LEMS. They have commercial operations. They mention expansion: Japan licensing agreement with DyDo for rights to develop/commercialize Firdapse in Japan, contributed $2.7 million revenue. Canada partnership with KYE, patients have access. But is that "copying a part of its own business" currently? They completed agreement with DyDo for Japan, contributed revenue. But is that standing up additional instances? They licensed rights to partner, not building own. Also "global footprint" expansion. But question asks "copying a part of its own business" - maybe not. Also business development: evaluating opportunities, hoping to complete acquisitions before end of year. Not currently standing up. Long-acting formulation: development, not proven. MuSK-MG: not proceeding? They are planning expert panel. No. The company is selling Firdapse in US, expanding to Japan/Canada via partnerships. But is that "currently in middle of copying" a proven instance? They have licensing agreements, but not physically standing up own operations. Demand? Japan deal contributed $2.7M, but that's revenue from license, not product sales. Canada via KYE. Not described as building additional instances. Question specifically: "management describe the company as CURRENTLY IN THE MIDDLE OF COPYING A PART OF ITS OWN BUSINESS THAT IS ALREADY WORKING INTO ADDITIONAL PLACES WHERE THE SAME DEMAND IS ALREADY VISIBLE" - Need all three. Management does not convey that. They mention expansion of global footprint, but not standing up copies. They mention business development but not proven. So answer NO. Need be careful: They have "Firdapse" product proven in US. They are expanding to Japan and Canada via partnerships. But are they "copying" their own business? They licensed rights to DyDo and KYE, not standing up their own instances. Also demand? They say "assist LEMS community worldwide" but not specific demand at destinations.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.